Cas:25018-67-1 Diacetone fructose manufacturer & supplier

Chemical Name:Diacetone fructose

CAS.NO:25018-67-1

Synonyms:1,2:4,5-DI-O-ISOPROPYLIDENE-BETA-D-FRUCTOPYRANOSE;1,2,4,5-Di-O-isopropylidene-b-D-fructopyranose;B-D-FRUCTOPYRANOSE;MFCD00067639;(3a’R,4S,7’S,7a’S)-2,2,2′,2′-Tetramethyltetrahydrospiro[1,3-dioxolane-4,6′-[1,3]dioxolo[4,5-c]pyran]-7′-ol;Diacetone fructose

Molecular Formula:C₁₂H₂₀O₆

Molecular Weight:260.284

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:379.0±42.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.522

PSA:66.38000

Exact Mass:260.125977

LogP:3.08

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2:4,5-DI-O-ISOPROPYLIDENE-BETA-D-FRUCTOPYRANOSE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Diacetone fructose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,B-D-FRUCTOPYRANOSE Use and application,B-D-FRUCTOPYRANOSE technical grade,usp/ep/jp grade.

Related News: According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, Benzo[b]thiophene-2-sulfonamide,5-chloro-3-methyl-N-[4-[(3R)-3-(1-methylethyl)-1-piperazinyl]-6-quinolinyl]- manufacturers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, N-[[4-[5-(hydroxymethyl)-3-phenylisoxazol-4-yl]phenyl]sulfonyl]acetamide suppliers “From the new company, we’ll be able to provide customers with invaluable access to high-quality sterile fill and finish capacity, which is in huge demand globally,” Recipharm CEO Marc Funk said in a release. tetrabromotellurate(II) vendor & factory MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world.,“From the new company, we’ll be able to provide customers with invaluable access to high-quality sterile fill and finish capacity, which is in huge demand globally,” Recipharm CEO Marc Funk said in a release.